On 10 April 2020, the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Africa Centres for Disease Control and Prevention (Africa CDC) launched a 5 million EUR call for proposals. The call aims to establish an African cohort of epidemiologists by supporting institutions in sub-Saharan Africa and Europe that develop such cadres through Master’s degree training in epidemiology and biostatistics.
Africa faces many challenges with its public health response to outbreaks - epidemiological data is often unavailable or severely limited; there is a shortage of skilled personnel and systems to collect and analyze available data, and efficiently translate this to inform policy and practice. The ongoing COVID-19 pandemic has exposed the severe shortages of the health research workforce, infrastructure and capacity for conducting research, as well as the capacity to develop drugs, vaccines, diagnostic tests and laboratory supplies in the African region.
The 10 successful projects (out of 45 applicants) will result in the training of a cohort of 150 epidemiologists recruited from across sub-Saharan Africa.
A network of 51 organisations are involved in the 10 successful projects - 42 organisations in West, East, Central and Southern regions of sub-Saharan Africa, 9 organisations in Europe. These 51 organisations include 24 leading universities in Europe and Africa, working in partnership with NPHIs, Ministries of Health, as well as other research and not for profit organisations.
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here